Researchers investigated polypharmacy incidence in one of the fastest-aging regions in Spain.
Findings of an observational cross-sectional study carried out in a Spanish nursing home revealed a high prevalence of polypharmacy and drug-related interactions among patients, with results underscoring the need for regular evaluation of drug prescribing to minimize associated risks.
Writing in the International Journal of Environmental Research and Public Health,researchers explained how currently, over 19% of the Spanish population is aged 65 or older, accounting for nearly a fifth of the country’s population. This total increased by more than 2 million in just 2 decades while projections estimate this population will grow in coming years.
“Ageing leads to an increased burden on health care systems, as older adults often have multiple diseases and require several medications, which favors polypharmacy,” authors wrote. Comorbidities, age-related physiological changes, and worsening of pre-existing conditions can all lead to poorer outcomes in this patient population, and thus may exacerbate polypharmacy.
In an effort to better elucidate the pattern of polypharmacy in an elderly population living in a nursing home and its relationship with drug-related problems (DRP), researchers assessed data collected between February and July 2021 from 222 residents. The nursing home is located in León, Spain, one of the country’s most aging regions.
All included drugs required a prescription and had been administered for at least 1 month prior to data collection, authors explained, with polypharmacy broken down into 3 categories: non-polypharmacy (0–4 medicines), polypharmacy (5–9 medicines), and excessive polypharmacy (at least 10 medicines).
Potentially inappropriate medication (PIM) was defined according to STOPP/START criteria, while software was used to classify severe and moderate drug-drug interactions (DDIs).
Mean (SD) patient age was 85.5 (7.8) years and the majority of patients (67.1%) were female; all study participants also had at least 2 chronic conditions with hypertension, cognitive impairment and cataracts being the most common.
Analyses revealed:
Findings align with results from previous studies, researchers wrote, adding “the main challenge associated with polypharmacy is the appearance of different DRPs, especially DDIs and ADRs.”
Polypharmacy also leads to increased drug costs and health care system utilization, while in recent years, improving drug prescription in elderly populations has garnered significant attention. Current Spanish guidelines recommend nursing home patients with polypharmacy have their medications reviewed every 6 months.
The study’s small sample size marks a limitation; over-the-counter medications were also not included in the analysis. Differences in prescribing between regions is also possible.
Overall, anticholinergic risk and comorbidities were significantly associated with polypharmacy in this study.
“Establishing a detailed understanding of the patterns and characteristics of potential inappropriate polypharmacy in the elderly may provide a basis for minimizing the health and economic consequences caused by inappropriate polypharmacy,” authors concluded.
Reference
Díez R, Cadenas R, Susperregui J, et al. Drug-related problems and polypharmacy in nursing home residents: a cross-sectional study. Int J Environ Res Public Health. Published online April 4, 2022. doi:10.3390/ijerph19074313
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
Generic Drug Savings Possibilities: $3.6 Billion to Medicare Using DTC Pricing
June 22nd 2022How much would have Medicare saved if it had the same ability to purchase generic drugs at the same price as individuals using direct-to-consumer (DTC) pharmacies like the Mark Cuban Cost Plus Drug Company? Billions, as it turns out.
Listen
Investigating How Care Fragmentation May Affect Primary Care Redesign in Medicare
March 20th 2022On this episode of Managed Care Cast, Lori Timmins, PhD, and Eugene Rich, MD, discuss the findings of their interim analysis of data from the first 3 years of the Comprehensive Primary Care Plus Initiative, a large-scale effort of primary care redesign meant to improve care fragmentation among Medicare fee-for-service beneficiaries.
Listen
More Care Doesn't Equal Happier Patients in Traditional Medicare
March 17th 2025Data on care satisfaction, ease managing care, and out-of-pocket spending were the outcomes of interest for this new analysis that investigated the relationship between healthcare utilization and beneficiary experience within traditional Medicare.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More